Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1625 1629 1691
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18551033 | NEW PROCESS FOR THE SYNTHESIS OF 5-{5-CHLORO-2-[(3S)-3-[(MORPHOLIN-4-YL)METHYL]-3,4-DIHYDROISOQUINOLINE-2(1H)- CARBONYL]PHENYL}-1,2-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID DERIVATIVES AND ITS APPLICATION FOR THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS | Non-Final OA | NOVARTIS AG |
| 17962656 | Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof | Non-Final OA | The Regents of the University of Colorado, a body corporate |
| 18041184 | PROTEASOME ENHANCERS AND USES THEREOF | Non-Final OA | Board of Trustees of Michigan State University |
| 18034439 | PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18576580 | FUNGICIDAL USE | Non-Final OA | Adama Makhteshim Ltd. |
| 18556376 | RETINOIC ACID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | Non-Final OA | JIANGXI KERUI PHARMACEUTICAL CO., LTD. |
| 18288318 | PURINE NUCLEOSIDES, THEIR INTERMEDIATES, AND METHODS OF PREPARATION THEREOF | Non-Final OA | The U.S.A., as Represented by the Secretary, Department of Health and Human Services |
| 18256680 | A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN | Final Rejection | THE SCRIPPS RESEARCH INSTITUTE |
| 18259696 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | Non-Final OA | VORONOI INC. |
| 17297269 | DILTIAZEM HYDROCHLORIDE AND PREGABALIN COMPOSITION, METHOD FOR PREPARING THE SAME, AND USAGE THEREOF | Non-Final OA | HAINAN JIN RUI PHARMACEUTICAL CO., LTD. |
| 17917891 | INJECTABLE MELATONIN COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES | Non-Final OA | UNIVERSIDAD DE GRANADA |
| 18264994 | NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES | Final Rejection | RAJA, Arun |
| 18340054 | USE OF FUBP1 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION | Non-Final OA | INSERM - INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE |
| 18335836 | CYCLIC LIPIDS AND METHODS OF USE THEREOF | Non-Final OA | ReNAgade Therapeutics Management Inc. |
| 18308288 | INHIBITORS OF ENPP1 AND MODULATION OF BONE GROWTH | Non-Final OA | Petragen, Inc. |
| 17576923 | PRODRUG COMPOSITIONS AND METHODS OF TREATMENT | Non-Final OA | AQUESTIVE THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy